M-CSF mediates host defense during bacterial pneumonia by promoting the survival of lung and liver mononuclear phagocytes

Journal of Immunology

Volumn 196, Issue 12, 2016, Pages 5047-5055

  Bettina, Alexandra ^a   Zhang, Zhimin ^a   Michels, Kathryn ^a   Elaine Cagnina, R ^a   Vincent, Isaah S ^a   Burdick, Marie D ^a   Kadl, Alexandra ^a   Mehrad, Borna ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL PNEUMONIA; CELL COUNT; CELL EXPANSION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENE DELETION; HOST RESISTANCE; IMMUNOMODULATION; KLEBSIELLA PNEUMONIAE; LIVER; LIVER NECROSIS; LUNG; LUNG INFECTION; LUNG INJURY; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; BONE MARROW; BONE MARROW CELL; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KLEBSIELLA INFECTION; MICROBIOLOGY; MONOCYTE; PATHOLOGY; PHAGOCYTE;

ANIMALS; ANTIBODIES, NEUTRALIZING; BONE MARROW; BONE MARROW CELLS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIVER; LUNG; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MONOCYTES; MONONUCLEAR PHAGOCYTE SYSTEM; PHAGOCYTES; PNEUMONIA, BACTERIAL;

EID: 84974824051     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600306     Document Type: Article

References (66)

1. Mehrad, B., N. M. Clark, G. G. Zhanel, and J. P. Lynch, III. 2015. Antimicrobial resistance in hospital-Acquired gram-negative bacterial infections. Chest 147: 1413-1421.
2. Mizgerd, J. P. 2008. Acute lower respiratory tract infection. N. Engl. J. Med. 358: 716-727.
3. Guilliams, M., F. Ginhoux, C. Jakubzick, S. H. Naik, N. Onai, B. U. Schraml, E. Segura, R. Tussiwand, and S. Yona. 2014. Dendritic cells, monocytes and macrophages: A unified nomenclature based on ontogeny. Nat. Rev. Immunol. 14: 571-578.
4. Schlitzer, A., N. McGovern, P. Teo, T. Zelante, K. Atarashi, D. Low, A. W. S. Ho, P. See, A. Shin, P. S. Wasan, et al. 2013. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38: 970-983.
5. Kopf, M., C. Schneider, and S. P. Nobs. 2015. The development and function of lung-resident macrophages and dendritic cells. Nat. Immunol. 16: 36-44.
6. Stanley, E. R., G. Hansen, J. Woodcock, and D. Metcalf. 1975. Colony stimulating factor and the regulation of granulopoiesis and macrophage production. Fed. Proc. 34: 2272-2278.
7. Stanley, E. R., M. Cifone, P. M. Heard, and V. Defendi. 1976. Factors regulating macrophage production and growth: identity of colony-stimulating factor and macrophage growth factor. J. Exp. Med. 143: 631-647.
8. Sauter, K. A., C. Pridans, A. Sehgal, Y. T. Tsai, B. M. Bradford, S. Raza, L. Moffat, D. J. Gow, P. M. Beard, N. A. Mabbott, et al. 2014. Pleiotropic effects of extended blockade of CSF1R signaling in adult mice. J. Leukoc. Biol. 96: 265-274.
9. Fancke, B., M. Suter, H. Hochrein, and M. OKeeffe. 2008. M-CSF: A novel plasmacytoid and conventional dendritic cell poietin. Blood 111: 150-159.
10. Mossadegh-Keller, N., S. Sarrazin, P. K. Kandalla, L. Espinosa, E. R. Stanley, S. L. Nutt, J. Moore, and M. H. Sieweke. 2013. M-CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature 497: 239-243.
11. Stanley, E. R., and V. Chitu. 2014. CSF-1 receptor signaling in myeloid cells. Cold Spring Harb. Perspect. Biol. 6: A021857.
12. Lin, H., E. Lee, K. Hestir, C. Leo, M. Huang, E. Bosch, R. Halenbeck, G. Wu, A. Zhou, D. Behrens, et al. 2008. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320: 807-811.
13. Nakamichi, Y., N. Udagawa, and N. Takahashi. 2013. IL-34 and CSF-1: similarities and differences. J. Bone Miner. Metab. 31: 486-495.
14. Baek, J.-H., R. Zeng, J. Weinmann-Menke, M. T. Valerius, Y. Wada, A. K. Ajay, M. Colonna, and V. R. Kelley. 2015. IL-34 mediates acute kidney injury and worsens subsequent chronic kidney disease. J. Clin. Invest. 125: 3198-3214.
15. Nandi, S., M. Cioce, Y.-G. Yeung, E. Nieves, L. Tesfa, H. Lin, A. W. Hsu, R. Halenbeck, H.-Y. Cheng, S. Gokhan, et al. 2013. Receptor-Type proteintyrosine phosphatase z is a functional receptor for interleukin-34. J. Biol. Chem. 288: 21972-21986.
16. Xiong, H., R. A. Carter, I. M. Leiner, Y.-W. Tang, L. Chen, B. N. Kreiswirth, and E. G. Pamer. 2015. Distinct Contributions of Neutrophils and CCR2+ Monocytes to Pulmonary Clearance of Different Klebsiella pneumoniae Strains. Infect. Immun. 83: 3418-3427.
17. Chen, L., Z. Zhang, K. E. Barletta, M. D. Burdick, and B. Mehrad. 2013. Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors. Am. J. Physiol. Lung Cell. Mol. Physiol. 305: L702-L711.
18. Roger, T., J. Delaloye, A.-L. Chanson, M. Giddey, D. Le Roy, and T. Calandra. 2013. Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis. J. Infect. Dis. 207: 331-339.
19. Pittet, L. A., L. J. Quinton, K. Yamamoto, B. E. Robson, J. D. Ferrari, H. Algul, R. M. Schmid, and J. P. Mizgerd. 2011. Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia. Am. J. Respir. Cell Mol. Biol. 45: 573-581.
20. Bailie, M. B., T. J. Standiford, L. L. Laichalk, M. J. Coffey, R. Strieter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumonia in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157: 5221-5224.
21. Bernier, T., R. Halter, D. Pau, S. Rittinghausen, and A. Emmendörffer. 2001. M-CSF transgenic mice: role of M-CSF in infection and autoimmunity. Exp. Toxicol. Pathol. 53: 165-173.
22. Gregory, S. H., E. J. Wing, D. J. Tweardy, R. K. Shadduck, and H. S. Lin. 1992. Primary listerial infections are exacerbated in mice administered neutralizing antibody to macrophage colony-stimulating factor. J. Immunol. 149: 188-193.
23. Doyle, A. G., W. J. Halliday, C. J. Barnett, T. L. Dunn, and D. A. Hume. 1992. Effect of recombinant human macrophage colony-stimulating factor 1 on immunopathology of experimental brucellosis in mice. Infect. Immun. 60: 1465-1472.
24. Kayashima, S., S. Tsuru, N. Shinomiya, Y. Katsura, K. Motoyoshi, M. Rokutanda, and N. Nagata. 1991. Effects of macrophage colony-stimulating factor on reduction of viable bacteria and survival of mice during Listeria monocytogenes infection: characteristics of monocyte subpopulations. Infect. Immun. 59: 4677-4680.
25. Cenci, E., A. Bartocci, P. Puccetti, S. Mocci, E. R. Stanley, and F. Bistoni. 1991. Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. Infect. Immun. 59: 868-872.
26. Barletta, K. E., R. E. Cagnina, M. D. Burdick, J. Linden, and B. Mehrad. 2012. Adenosine A(2B) receptor deficiency promotes host defenses against gramnegative bacterial pneumonia. Am. J. Respir. Crit. Care Med. 186: 1044-1050.
27. Mehrad, B., S. J. Park, G. Akangire, T. J. Standiford, T. Wu, J. Zhu, and C. Mohan. 2006. The lupus-susceptibility locus, Sle3, mediates enhanced resistance to bacterial infections. J. Immunol. 176: 3233-3239.
28. Yona, S., K.-W. Kim, Y. Wolf, A. Mildner, D. Varol, M. Breker, D. Strauss-Ayali, S. Viukov, M. Guilliams, A. Misharin, et al. 2013. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. [Published erratum appears in 2013 Immunity 38:1073-9.] Immunity 38: 79-91.
29. Park, S. J., M. T. Wiekowski, S. A. Lira, and B. Mehrad. 2006. Neutrophils regulate airway responses in a model of fungal allergic airways disease. J. Immunol. 176: 2538-2545.
30. Barletta, K. E., R. E. Cagnina, K. L. Wallace, S. I. Ramos, B. Mehrad, and J. Linden. 2012. Leukocyte compartments in the mouse lung: distinguishing between marginated, interstitial, and alveolar cells in response to injury. J. Immunol. Methods 375: 100-110.
31. Park, S. J., M. D. Burdick, W. K. Brix, M. H. Stoler, D. S. Askew, R. M. Strieter, and B. Mehrad. 2010. Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-To-chemokine amplification loop. J. Immunol. 185: 6190-6197.
32. Phadke, A. P., G. Akangire, S. J. Park, S. A. Lira, and B. Mehrad. 2007. The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. Am. J. Respir. Crit. Care Med. 175: 1165-1172.
33. Misharin, A. V., L. Morales-Nebreda, G. M. Mutlu, G. R. S. Budinger, and H. Perlman. 2013. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. Am. J. Respir. Cell Mol. Biol. 49: 503-510.
34. Weischenfeldt, J., and B. Porse. 2008. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. 2008: pdb.prot5080.
35. Beletskii, A., M. Cooper, P. Sriraman, C. Chiriac, L. Zhao, S. Abbot, and L. Yu. 2005. High-Throughput phagocytosis assay utilizing a pH-sensitive fluorescent dye. Biotechniques 39: 894-897.
36. Schack, L., R. Stapulionis, B. Christensen, E. Kofod-Olsen, U. B. Skov Sørensen, T. Vorup-Jensen, E. S. Sørensen, and P. Höllsberg. 2009. Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J. Immunol. 182: 6943-6950.
37. Shibata, Y., Z. Zsengeller, K. Otake, N. Palaniyar, and B. C. Trapnell. 2001. Alveolar macrophage deficiency in osteopetrotic mice deficient in macrophage colony-stimulating factor is spontaneously corrected with age and associated with matrix metalloproteinase expression and emphysema. Blood 98: 2845-2852.
38. MacDonald, K. P. A., J. S. Palmer, S. Cronau, E. Seppanen, S. Olver, N. C. Raffelt, R. Kuns, A. R. Pettit, A. Clouston, B. Wainwright, et al. 2010. An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue-And tumor-Associated macrophages but does not inhibit inflammation. Blood 116: 3955-3963.
39. Louis, C., A. D. Cook, D. Lacey, A. J. Fleetwood, R. Vlahos, G. P. Anderson, and J. A. Hamilton. 2015. Specific Contributions of CSF-1 and GM-CSF to the Dynamics of the Mononuclear Phagocyte System. J. Immunol. 195: 134-144.
40. Hettinger, J., D. M. Richards, J. Hansson, M. M. Barra, A.-C. Joschko, J. Krijgsveld, and M. Feuerer. 2013. Origin of monocytes and macrophages in a committed progenitor. Nat. Immunol. 14: 821-830.
41. Jenkins, S. J., D. Ruckerl, G. D. Thomas, J. P. Hewitson, S. Duncan, F. Brombacher, R. M. Maizels, D. A. Hume, and J. E. Allen. 2013. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J. Exp. Med. 210: 2477-2491.
42. Tagliani, E., C. Shi, P. Nancy, C.-S. Tay, E. G. Pamer, and A. Erlebacher. 2011. Coordinate regulation of tissue macrophage and dendritic cell population dynamics by CSF-1. J. Exp. Med. 208: 1901-1916.
43. Tushinski, R. J., I. T. Oliver, L. J. Guilbert, P. W. Tynan, J. R. Warner, and E. R. Stanley. 1982. Survival of mononuclear phagocytes depends on a lineagespecific growth factor that the differentiated cells selectively destroy. Cell 28: 71-81.
44. Saini, Y., K. J. Wilkinson, K. A. Terrell, K. A. Burns, A. Livraghi-Butrico, C. M. Doerschuk, W. K. ONeal, and R. C. Boucher. 2016. Neonatal Pulmonary Macrophage Depletion Coupled to Defective Mucus Clearance Increases Susceptibility to Pneumonia and Alters Pulmonary Immune Responses. Am. J. Respir. Cell Mol. Biol. 54: 210-221.
45. Broug-Holub, E., G. B. Toews, J. F. van Iwaarden, R. M. Strieter, S. L. Kunkel, R. Paine, III, and T. J. Standiford. 1997. Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect. Immun. 65: 1139-1146.
46. Gregory, S. H., and E. J. Wing. 1993. Macrophage colony-stimulating factor and the enhanced migration of monocytes are essential in primary but not secondary host defenses to Listeria organisms. J. Infect. Dis. 168: 934-942.
47. Higgins, D. M., J. Sanchez-Campillo, A. G. Rosas-Taraco, J. R. Higgins, E. J. Lee, I. M. Orme, and M. Gonzalez-Juarrero. 2008. Relative levels of M-CSF and GMCSF influence the specific generation of macrophage populations during infection with Mycobacterium tuberculosis. J. Immunol. 180: 4892-4900.
48. Nascimento, M., S. C. Huang, A. Smith, B. Everts, W. Lam, E. Bassity, E. L. Gautier, G. J. Randolph, and E. J. Pearce. 2014. Ly6Chi monocyte recruitment is responsible for Th2 associated host-protective macrophage accumulation in liver inflammation due to schistosomiasis. PLoS Pathog. 10: e1004282.
49. Fuller, K., J. M. Owens, C. J. Jagger, A. Wilson, R. Moss, and T. J. Chambers. 1993. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med. 178: 1733-1744.
50. Melcher, M., B. Unger, U. Schmidt, I. A. Rajantie, K. Alitalo, and W. Ellmeier. 2008. Essential roles for the Tec family kinases Tec and Btk in M-CSF receptor signaling pathways that regulate macrophage survival. J. Immunol. 180: 8048-8056.
51. Glantschnig, H., J. E. Fisher, G. Wesolowski, G. A. Rodan, and A. A. Reszka. 2003. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ. 10: 1165-1177.
52. Otero, K., I. R. Turnbull, P. L. Poliani, W. Vermi, E. Cerutti, T. Aoshi, I. Tassi, T. Takai, S. L. Stanley, M. Miller, et al. 2009. Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat. Immunol. 10: 734-743.
53. Dockrell, D. H., H. M. Marriott, L. R. Prince, V. C. Ridger, P. G. Ince, P. G. Hellewell, and M. K. B. Whyte. 2003. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J. Immunol. 171: 5380-5388.
54. Marriott, H. M., P. G. Hellewell, S. S. Cross, P. G. Ince, M. K. B. Whyte, and D. H. Dockrell. 2006. Decreased alveolar macrophage apoptosis is associated with increased pulmonary inflammation in a murine model of pneumococcal pneumonia. J. Immunol. 177: 6480-6488.
55. González-Juarbe, N., R. P. Gilley, C. A. Hinojosa, K. M. Bradley, A. Kamei, G. Gao, P. H. Dube, M. A. Bergman, and C. J. Orihuela. 2015. Pore-Forming Toxins Induce Macrophage Necroptosis during Acute Bacterial Pneumonia. PLoS Pathog. 11: e1005337.
56. Kitur, K., D. Parker, P. Nieto, D. S. Ahn, T. S. Cohen, S. Chung, S. Wachtel, S. Bueno, and A. Prince. 2015. Toxin-induced necroptosis is a major mechanism of Staphylococcus aureus lung damage. PLoS Pathog. 11: e1004820.
57. Ogiku, M., H. Kono, K. Ishii, N. Hosomura, and H. Fujii. 2011. Role of macrophage colony-stimulating factor in polymicrobial sepsis according to studies using osteopetrotic (op/op) mice. J. Surg. Res. 169: 106-116.
58. Schönlau, F., C. Schlesiger, J. Ehrchen, S. Grabbe, C. Sorg, and C. Sunderkö tter. 2003. Monocyte and macrophage functions in M-CSF-deficient op/op mice during experimental leishmaniasis. J. Leukoc. Biol. 73: 564-573.
59. Roilides, E., T. Sein, A. Holmes, S. Chanock, C. Blake, P. A. Pizzo, and T. J. Walsh. 1995. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis. 172: 1028-1034.
60. Siu, L. K., K.-M. Yeh, J.-C. Lin, C.-P. Fung, and F.-Y. Chang. 2012. Klebsiella pneumoniae liver abscess: A new invasive syndrome. Lancet Infect. Dis. 12: 881-887.
61. Hilliard, K. L., E. Allen, K. E. Traber, K. Yamamoto, N. M. Stauffer, G. A. Wasserman, M. R. Jones, J. P. Mizgerd, and L. J. Quinton. 2015. The Lung-Liver Axis: A Requirement for Maximal Innate Immunity and Hepatoprotection during Pneumonia. Am. J. Respir. Cell Mol. Biol. 53: 378-390.
62. Moore, T. A., H. Y. Lau, A. L. Cogen, C. L. Monteleon, and T. J. Standiford. 2003. Anti-Tumor necrosis factor-Alpha therapy during murine Klebsiella pneumoniae bacteremia: increased mortality in the absence of liver injury. Shock 20: 309-315.
63. Moore, T. A., M. L. Perry, A. G. Getsoian, C. L. Monteleon, A. L. Cogen, and T. J. Standiford. 2003. Increased mortality and dysregulated cytokine production in tumor necrosis factor receptor 1-deficient mice following systemic Klebsiella pneumoniae infection. Infect. Immun. 71: 4891-4900.
64. Stutchfield, B. M., D. J. Antoine, A. C. Mackinnon, D. J. Gow, C. C. Bain, C. A. Hawley, M. J. Hughes, B. Francis, D. Wojtacha, T. Y. Man, et al. 2015. CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure. Gastroenterology 149: 1896-1909.e1814.
65. Taut, K., C. Winter, D. E. Briles, J. C. Paton, J. W. Christman, R. Maus, R. Baumann, T. Welte, and U. A. Maus. 2008. Macrophage Turnover Kinetics in the Lungs of Mice Infected with Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 38: 105-113.
66. Hume, D. A., and K. P. A. MacDonald. 2012. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. Blood 119: 1810-1820.